Prognostic and Predictive Factors of Early Breast Cancer

References

1. ↵
   1. Botteri E,
   2. Bagnardi V,
   3. Goldhirsch A, et al.

   Axillary lymph node involvement in women with breast cancer: does it depend on age? Clin Breast Cancer 2010; 10: 318-321.

   OpenUrlPubMed
2. ↵
   1. Bollet MA,
   2. Kirova YM,
   3. Fourquet A, et al.

   Prognostic factors for local recurrence following breast-conserving treatment in young women. Expert Rev Anticancer Ther 2010; 10: 1215-1227.

   OpenUrlPubMed
3. ↵
   1. Poparlan T,
   2. Musca S.

   Role of prognostic factors in evaluation of survival in breast cancer. Rev Med Chir Soc Med Nat lasi 2010; 114: 147-151.

   OpenUrl
4. 1. Schnitt SJ.

   Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 2010; 23 Suppl 2: S60-4.

   OpenUrlCrossRefPubMedWeb of Science
5. 1. Sasano H.

   Histopathological prognostic factors in early breast carcinoma: an evaluation of cell proliferation in carcinoma cells. Expert Opin Investig Drugs 2010; 19 Suppl 1: S5-11.

   OpenUrl
6. 1. Kheradmand AA,
   2. Ranjbarnovin N,
   3. Khazaeipour Z.

   Postmastectomy locoregional recurrence a3nd recurrence-free survival in breast cancer patients. World J Surg Oncol 2010; 8: 30.

   OpenUrlPubMed
7. 1. Lialiaris TS,
   2. Georgiou G,
   3. Sivridis E, et al.

   Prognostic and predictive factors of invasive ductal breast carcinomas. J MUON 2010; 15: 79-88.

   OpenUrl
8. 1. Van Nes JG,
   2. Putter H,
   3. Van Hezewijk M, et al.

   Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence. Eur J Surg Oncol 2010; 36: 617-624.

   OpenUrlPubMed
9. 1. Ibrahim EM,
   2. Elkhodary TR,
   3. Zekri JM, et al.

   Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia. Asia Pac J Clin Oncol 2010; 6: 130-137.

   OpenUrlPubMed
10. 1. Baneshi MR,
    2. Warner P,
    3. Anderson N, et al.

    Tamoxifen resistance in early breast cancer: statistical modeling of tissue markers to improve risk prediction. Br J Cancer 2010; 102: 1503-1510.

    OpenUrlPubMed
11. ↵
    1. Karanikas G,
    2. Koronakis N,
    3. Lagoudianakis EE, et al.

    The value of proliferation indexes in breast cancer. Eur J Gynaecol Oncol 2010; 31: 181-184.

    OpenUrlPubMed
12. ↵
    1. Katz A,
    2. Strom EA,
    3. Buchholz TA, et al.

    Loco-regional recurrence patterns following mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 2000; 18: 2817-2827.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Smith BD,
    2. Smith GL,
    3. Haffty BG, et al.

    Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol 2005; 23: 1409-1419.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Truong PT,
    2. Woodward WA,
    3. Thames HD, et al.

    The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: An analysis of prospective data from British Columbia and the M.D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2007; 68: 59-65.

    OpenUrlPubMedWeb of Science
15. ↵
    1. Fortin A,
    2. Dagnault A,
    3. Blondeau L, et al.

    The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation. Int J Radiat Oncol Biol Phys 2006; 65: 33-39.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Tai P,
    2. Yu E,
    3. Joseph K.

    Prognostic significance of number of positive nodes: a long-term study of one to two nodes versus three nodes in breast cancer patients. Int J Radiat Oncol Biol Phys 2010; 77: 180-187.

    OpenUrlPubMed
17. ↵
    1. Maalej M,
    2. Gargouri W,
    3. Kochbati L, et al.

    Internal mammary lymph node invasion in breast cancer: myth or reality? Tunis Med 2009; 87: 319-322.

    OpenUrlPubMed
18. ↵
    1. Sullivan T,
    2. Raad RA,
    3. Goldberg S, et al.

    Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat 2005; 93: 199-205.

    OpenUrlPubMed
19. ↵
    1. Peng L,
    2. Sun Q,
    3. Liang ZY, et al.

    Pure mucinous carcinoma of the breast: a clinicopathologic analysis with 56 patients. Chin Med Sci J 2010; 25: 115-118 (Chinese).

    OpenUrlPubMed
20. ↵
    1. Botteri E,
    2. Bagnardi V,
    3. Rotmensz N, et al.

    Analysis of local and regional recurrences in breast cancer after conservative surgery. AnnOncol 2010; 21: 723-728.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Dent R,
    2. Hanna WM,
    3. Trudeau M, et al.

    Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status. Cancer 2009; 115: 4917-4923.

    OpenUrlPubMed
22. ↵
    1. Quiet CA,
    2. Ferguson DJ,
    3. Weichselbaum RR, et al.

    Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 1995; 13:1144-1151.

    OpenUrlAbstract
23. ↵
    1. Ragage F,
    2. Debled M,
    3. MacGrogan G, et al.

    Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer? Cancer 2010; 116: 3093-3101.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    1. Tantivatana T,
    2. Chongthanakorn M,
    3. Rongsriyam K, et al.

    Treatment outcomes and prognostic factors of patients with breast cancer: a retrospective review. J Med Assoc Thai 2009; 92: 1084-1093.

    OpenUrlPubMed
25. ↵
    1. Chen JY,
    2. Ma XJ,
    3. Zhou WB, et al.

    Radiotherapy for and prognosis of breast cancer patients with local-regional recurrence after mastectomy. Ai Zheng 2009; 28: 1077-1082 (Chinese).

    OpenUrlPubMed